Skip to content Skip to sidebar Skip to footer

Blue Chip Stocks Healthcare Stocks Large Caps Life Sciences

Sick Charts: Why The ASX’s 3 Pathology Stocks Are All Under the Weather

The ASX's 3 pathology stocks: Sonic Healthcare (ASX:SHL), Healius (ASX:HLS) and Australian Clinical Labs (ASX:ACL); have delivered a torrid experience for shareholders over the past two to three years. Sonic, the…

ByNick Sundich

Mar 2026

Healthcare Stocks

The 4 Best ASX Healthcare Stocks to Buy as the Sector Trades at Two-Decade Valuation Lows

4 ASX Healthcare Stocks to Buy at Valuation Lows ASX healthcare stocks have had a brutal run. Five years of underperformance, persistent earnings downgrades, and aggressive rate hikes have pushed…

ByUjjwal Maheshwari

Jan 2026

Healthcare Stocks

Sonic Healthcare (ASX:SHL): Australia’s biggest pathology stock is available at a bargain price

It is not often that you can buy a blue-chip stock at a bargain price, but Sonic Healthcare (ASX:SHL) is such an opportunity. What are the Best ASX Stocks to invest…

ByNick Sundich

Jul 2025

Dividend Stocks Education Healthcare Stocks

What are the best ASX shares for dividend investing? They all belong to these 4 sectors

What are the best ASX shares for dividend investing? It is difficult to pick individual stocks because dividends can fluctuate from year to year. However, the best…

ByNick Sundich

Mar 2023

General

1HY23 reporting season is over: Here are 5 of the best results from ASX companies

With 1HY23 reporting season completed, Stocks Down Under looks at 5 of the best results. These companies may not have necessarily recorded the highest growth or largest profit, but they have…

ByNick Sundich

Feb 2023

Uncategorized

Ageing population stocks are set to derive significant long-term value

Ageing population stocks represent among the best long-term opportunities that exist for investors. Over the next 25 years, the world's population of people over 60 will double. Looking specifically at Australia, the…

ByNick Sundich

Feb 2023

Life Sciences

Why did biotech shares underperform in 2022 and will they rebound with a vengence in 2023?

In the past year, biotech shares have performed poorly. Why has this been the case and will things be better in 2023? SIGN UP FOR THE STOCKS DOWN UNDER NEWSLETTER NOW!…

ByNick Sundich

Feb 2023

Financials

It’s earnings season once again and here are 4 ASX stocks investors should watch

This month, it is earnings season once again. All ASX stocks have to release financial results every 6 months, no more than 2 months after the end of either the half-year…

ByNick Sundich

the Kick-ass Multipurpose WordPress Theme

Sick Charts: Why The ASX’s 3 Pathology Stocks Are All Under the Weather

The 4 Best ASX Healthcare Stocks to Buy as the Sector Trades at Two-Decade Valuation Lows

Sonic Healthcare (ASX:SHL): Australia’s biggest pathology stock is available at a bargain price

What are the best ASX shares for dividend investing? They all belong to these 4 sectors

1HY23 reporting season is over: Here are 5 of the best results from ASX companies

Ageing population stocks are set to derive significant long-term value

Why did biotech shares underperform in 2022 and will they rebound with a vengence in 2023?

It’s earnings season once again and here are 4 ASX stocks investors should watch

PLS Group (ASX:PLS) Hits Record High on...

Narryer Metals (ASX:NYM) Tim Goyder Back...

Sovereign Metals (ASX:SVM) DFS lands,$2....

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Add Your Heading Text Here